Gainers

  • American Electric Technologies, IncAETI shares surged 126.35 percent to close at $1.675 on Monday after the company’s M&I Electric business announced a $14 million project with a leading Engineering, Procurement and Construction firm.
  • Deciphera Pharmaceuticals, Inc. DCPHshares gained 47.86 percent to close at $38.31 after the company reported updated interim Phase 1 clinical study results with DCC-2618 at the ASCO Annual Meeting.
  • Anavex Life Sciences Corp. AVXLgained 31.71 percent to close at $3.78.
  • LiveXLive Media, Inc. LIVXrose 24.94 percent to close at $5.56.
  • Genomic Health, Inc.GHDX shares rose 23.07 percent to close at $48.84 after the company disclosed that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, successfully defined the benefit of chemotherapy in early-stage breast cancer patients with Oncotype DX Breast Recurrence Score® results of 11 to 25.
  • Highpower International IncHPJ shares rose 18.26 percent to close at $3.40 on Monday.
  • Renmin Tianli Group, Inc. ABACgained 17.51 percent to close at $2.55.
  • BIO-key International, Inc. BKYIrose 17.04 percent to close at $2.61. BIO-key International disclosed that it has completed conversion of all outstanding preferred stock into common stock at a conversion price of $3.60 per share.
  • Rocket Pharmaceuticals, Inc. RCKTrose 15.87 percent to close at $23.00.
  • Companhia Siderúrgica NacionalSID climbed 14.98 percent to close at $2.38 on Monday.
  • ASLAN Pharmaceuticals LimitedASLN shares rose 14.92 percent to close at $9.78.
  • ProQR Therapeutics N.V. PRQRclimbed 13.91 percent to close at $6.55.
  • Sogou Inc. SOGOgained 13.22 percent to close at $10.88 on Monday.
  • Evolus, Inc. EOLSgained 11.77 percent to close at $30.49.
  • Arcturus Therapeutics Ltd. ARCTshares rose 11.55 percent to close at $6.28 on Monday.
  • CSS Industries, Inc.CSS rose 11.19 percent to close at $17.99. DA Davidson upgraded CSS Industries from Neutral to Buy.
  • Denali Therapeutics Inc. DNLIgained 10.4 percent to close at $20.80.
  • Immunomedics, Inc.IMMU shares rose 10.26 percent to close at $25.04. Clovis Oncology and Immunomedics reported a planned clinical collaboration to study combination therapies in metastatic triple-negative breast and urothelial cancers.
  • Petróleo Brasileiro S.A. – PetrobrasNYSEPBRA shares rose 9.7 percent to close at $9.39.

 

Losers

  • Nektar Therapeutics NKTRshares tumbled 41.82 percent to close at $52.57 on Monday. Nektar and Bristol-Myers Squibb reported preliminary data for NKTR-214 in combination with opdivo for patients with Stage IV metastatic melanoma, renal cell carcinoma, and urothelial cancers.
  • Jounce Therapeutics, Inc.JNCE dropped 33.48 percent to close at $7.47 after the company presented preliminary data from its ongoing Phase 1/2 ICONIC trial of JTX-2011 in patients with advanced solid tumors.
  • Kandi Technologies Group, Inc. KNDIshares fell 29.36 percent to close at $3.85. The company announced that it was acquiring Sportsman Country for $10 million in restricted shares.
  • Mersana Therapeutics, Inc. MRSNslipped 23 percent to close at $15.94 after the company presented interim dose-escalation data on XMT-1522 in select cancers at the ASCO 2018.
  • Daqo New Energy Corp.DQ shares declined 20.71 percent to close at $41.80 on Monday after dropping 8.57 percent on Friday.
  • Vaxart, Inc.VXRT fell 18.32 percent to close at $4.28 as the company disclosed that its Phase 2 trial of teslexivir did not meet its primary endpoint.
  • AC Immune SAACIU dropped 18.27 percent to close at $8.320.
  • CytomX Therapeutics, Inc. CTMXdeclined 16.26 percent to close at $21.38.
  • Amtech Systems, Inc. ASYSfell 16.13 percent to close at $8.32 on Monday.
  • Aduro BioTech, Inc. ADROshares dropped 15.38 percent to close at $7.15.
  • RF Industries, Ltd. RFILshares slipped 14.79 percent to close at $6.05 on Monday.
  • Gevo, Inc. GEVOshares fell 14.58 percent to close at $4.10 on Monday.
  • Canadian Solar Inc. CSIQshares dropped 13.86 percent to close at $13.515.
  • Obalon Therapeutics, Inc. OBLNshares dipped 13.04 percent to close at $2.20.
  • Corvus Pharmaceuticals, Inc. CRVSshares tumbled 12.29 percent to close at $11.56.
  • Zymeworks Inc. ZYMEfell 12.21 percent to close at $19.19 on Monday.
  • Syndax Pharmaceuticals, Inc.SNDX dropped 12.02 percent to close at $7.76
  • G1 Therapeutics, Inc. GTHXshares fell 10.16 percent to close at $39.17 after the company presented Phase 1b data on G1T38 in combination with faslodex for treatment of breast cancer at the ASCO 2018.
  • PPDAI Group Inc. PPDFshares declined 9.75 percent to close at $6.94 on Monday.
  • Blueprint Medicines Corporation BPMCshares dropped 9.24 percent to close at $76.67. Blueprint Medicines and CStone Pharmaceuticals reported a partnership and license agreement to develop and commercialize Avapritinib, BLU-554 and BLU-667 in Greater China.
  • JinkoSolar Holding Co., Ltd.JKS fell 9.05 percent to close at $13.77 on Monday after dropping 14.07 percent on Friday.
  • NovoCure LimitedNVCR dropped 7.51 percent to close at $29.55. Novocure will present INNOVATE-3 Phase 3 pivotal trial design in recurrent ovarian cancer at the ASCO Annual Meeting 2018.
  • Co-Diagnostics, Inc.CODX fell 7.31 percent to close at $4.44 on Monday after climbing 65.17 percent on Friday.
  • Tactile Systems Technology, Inc.TCMD slipped 7.08 percent to close at $46.87. BTIG Research downgraded Tactile Systems Technology from Buy to Neutral.
  • Viper Energy Partners LPVNOM dropped 6.18 percent to close at $28.52. Stifel Nicolaus downgraded Viper Energy Partners from Buy to Hold.